Stockreport

Roche's implant for chronic eye disorder wins U.S. approval [Financial Post (Toronto, Ontario, Canada)]

ROCHE HOLDING LTD S/ADR  (RHHBY) 
NASDAQ:AMEX Investor Relations: roche.com/investors.htm
PDF causing blurred vision, giving patients an alternative to receiving monthly eye injections with existing treatments. The surgically implantable device Susvimo is inten [Read more]